133
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Association between diabetes complications and leukocyte counts in Iranian patients

, , &
Pages 7-11 | Published online: 24 Jan 2012

References

  • American Diabetes AssociationStandards of medical care in diabetes – 2011Diabetes Care201134Suppl 1S116121193625
  • DandonaPAljadaAA rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosisAm J Cardiol2002905A27G33G
  • KingHAubertREHermanWHGlobal burden of diabetes, 1995–2025 prevalence, numerical estimates, and projectionsDiabetes Care1998219141414319727886
  • JohnstonSSConnerCAagrenMSmithDMBouchardJBrettJEvidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetesDiabetes Care20113451164117021421802
  • BunceCWormaldRCauses of blind certifications in England and WalesEye200822790591117332762
  • AvisarRFrilingRSnirMAvisarIWeinbergerDEstimation of prevalence and incidence rates and causes of blindness in Israel, 1998–2003Isr Med Assoc J200681288088117214111
  • CusumanoAGarcia-GarciaGDi GioiaCEnd-stage renal disease and its treatment in Latin America in the twenty-first centuryRen Fail200628863163717162420
  • InsullWJrThe pathology of atherosclerosis: plaque development and plaque responses to medical treatmentAm J Med2009122Suppl 1S31419110086
  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)UK Prospective Diabetes Study (UKPDS) GroupLancet199835291318378539742976
  • The diabetes control and complications trial research group: The effect of intensive treatment of diabetes on development and progression of long term complications in insulin dependent diabetes mellitusN Eng J Med199332914997986
  • StamlerJVaccaroONeatonJDWentworthDDiabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care19931624344448432214
  • RossRAtherosclerosis-an inflammatory diseaseN Engl J Med1999340241151269887164
  • WeijenbergMPFeskensEJKromhoutDWhite blood cell count and the risk of coronary heart disease and all-cause mortality in elderly menArterioscler Thromb Vasc Biol19961644995038624770
  • TongPCLeeKFSoWYWhite blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetesDiabetes Care200427121622214693992
  • HeidlandASebekovaKSchinzelRAdvanced glycation end products and the progressive course of renal diseaseAm J Kidney Dis2001384S10010611576932
  • VlassaraHFuhHDonnellyTCybulskyMAdvanced glycation end products promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbitsMol Med1995144474568521302
  • VlassaraHBrownleeMManogueKRDinarelloCAPasagianACachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelingScience19882404858154615483259727
  • EspositoCGerlachHBrettJSternDVlassaraHEndothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant propertiesJ Exp Med19891704138714072551990
  • AndersenJUMauricioDKarlsenAEMandrup-PoulsenTNielsenJHNerupJInterleukin-1B-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methylxanthineEur J Endocrinol199613422512598630528
  • American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201033Suppl 1S626920042775
  • StrejaDCresseyPRabkinSWAssociations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitusJ Diabetes Complications200317312012712738395
  • KangESKimHJAhnCWRelationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetesDiabetes Res Clin Pract200569215115916005364
  • HanleyAJKarterAJFestaAFactor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis StudyDiabetes20025182642264712145182
  • ChealKLAbbasiFLamendolaCMcLaughlinTReavenGMFordESRelationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndromeDiabetes20045351195120015111486
  • CarrDBUtzschneiderKMHullRLIntra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndromeDiabetes20045382087209415277390
  • BoMMassaiaMRaspoSPredictive factors of in-hospital mortality in older patients admitted to a medical intensive care unitJ Am Geriatr Soc200351452953312657074
  • ChungFMTsaiJCChangDMShinSJLeeYJPeripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosisDiabetes Care20052871710171715983324
  • TsaiJCSheuSHChiuHCAssociation of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitusDiabetes Metab Res Rev200723211111816703635
  • FestaAD’AgostinoRJrHowardGMykkänenLTracyRPHaffnerSMChronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS)Circulation20001021424710880413
  • FröhlichMImhofABergGAssociation between C-reactive protein and features of the metabolic syndrome: a population-based studyDiabetes Care200023121835183911128362
  • PécsvarádyZFisherTCDarwinCHDecreased polymorphonuclear leukocyte deformability in NIDDMDiabetes Care199417157638112190
  • Alba-LoureiroTCMunhozCDMartinsJONeutrophil function and metabolism in individuals with diabetes mellitusBraz J Med Biol Res20074081037104417665039
  • StegengaMEVander CrabbenSNDessingMCEffect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humansDiabet Med200825215716418290856